azathioprine has been researched along with Hepatic Failure in 9 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Factors associated with HCV recurrence were evaluated." | 2.79 | Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. ( Burroughs, AK; Cholongitas, E; Corbani, A; Davidson, B; Davidson, J; Dhillon, AP; Hayes, P; Luong, T; Manousou, P; McCormick, PA; O'Beirne, J; Patch, D; Rodríguez-Perálvarez, M; Rolles, K; Samonakis, D; Thorburn, D; Tsochatzis, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sokollik, C | 1 |
| McLin, VA | 1 |
| Vergani, D | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Mieli-Vergani, G | 1 |
| Manousou, P | 1 |
| Cholongitas, E | 1 |
| Samonakis, D | 1 |
| Tsochatzis, E | 1 |
| Corbani, A | 1 |
| Dhillon, AP | 1 |
| Davidson, J | 1 |
| Rodríguez-Perálvarez, M | 1 |
| Patch, D | 1 |
| O'Beirne, J | 1 |
| Thorburn, D | 1 |
| Luong, T | 1 |
| Rolles, K | 1 |
| Davidson, B | 1 |
| McCormick, PA | 1 |
| Hayes, P | 1 |
| Burroughs, AK | 1 |
| Soares, JC | 1 |
| Borgonovo, A | 1 |
| Maggi, DC | 1 |
| Pasinato, AP | 1 |
| Ramos, FG | 1 |
| Dantas-Corrêa, EB | 1 |
| Schiavon, LL | 1 |
| Narciso-Schiavon, JL | 1 |
| Kim, BH | 1 |
| Kim, YJ | 1 |
| Jeong, SH | 1 |
| Tak, WY | 1 |
| Ahn, SH | 1 |
| Lee, YJ | 1 |
| Jung, EU | 1 |
| Lee, JI | 1 |
| Yeon, JE | 1 |
| Hwang, JS | 1 |
| Um, SH | 1 |
| Seo, YS | 1 |
| Kim, YS | 1 |
| Song, BC | 1 |
| Kim, JH | 1 |
| Jung, YK | 1 |
| Park, CK | 1 |
| Kim, KA | 1 |
| Min, HJ | 1 |
| Cho, EY | 1 |
| Lee, ES | 1 |
| Kwon, SY | 1 |
| Chae, HB | 1 |
| Kim, DJ | 1 |
| Shin, SR | 1 |
| Lemmens, HP | 1 |
| Langrehr, JM | 1 |
| Blumhardt, G | 1 |
| Lohmann, R | 1 |
| Knoop, M | 1 |
| Verschl, J | 1 |
| Schattenfroh, N | 1 |
| Neuhaus, R | 1 |
| Hopf, U | 1 |
| Bechstein, WO | 1 |
| Bhaskaran, S | 1 |
| Mani, MK | 1 |
| Prakash, KC | 1 |
| Malagó, M | 1 |
| Rogiers, X | 1 |
| Wadström, J | 1 |
| Burdelski, M | 1 |
| Broelsch, CE | 1 |
| Fouad, FM | 1 |
| Mamer, OA | 1 |
| Shahidi, F | 1 |
| Newell, KA | 1 |
| Alonso, EM | 1 |
| Kelly, SM | 1 |
| Rubin, CM | 1 |
| Thistlethwaite, JR | 1 |
| Whitington, PF | 1 |
1 review available for azathioprine and Hepatic Failure
| Article | Year |
|---|---|
Juvenile autoimmune hepatitis: A comprehensive review.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Disease Management; | 2018 |
1 trial available for azathioprine and Hepatic Failure
| Article | Year |
|---|---|
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hum | 2014 |
7 other studies available for azathioprine and Hepatic Failure
| Article | Year |
|---|---|
Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Biomarkers; Cross | 2016 |
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; A | 2013 |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedu | 1994 |
A study of hepatitis B surface antigen positive patients on haemodialysis and following transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aspartate Aminotransferases; Azathioprine; Child; Femal | 1994 |
Optimal clinical regimens for living related liver transplantation.
Topics: Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Drug Administration Sched | 1994 |
Biogenesis of hepatic acute-phase response to trauma.
Topics: Acute-Phase Proteins; Animals; Azathioprine; Blood Proteins; Carbon Tetrachloride Poisoning; Humans; | 1996 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Foll | 1997 |